Latest News and Press Releases

CHASKA, Minn., April 22, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...

Lipella Reports Positive Phase 2a Results from Second LP-310 Cohort in Oral Lichen Planus; Final Data Expected Q2 2025

CINCINNATI, April 08, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) (formerly Blue Water Biotech Inc.) and Ocuvex Therapeutics, Inc. (“Ocuvex”), a privately...

Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus

Detroit, April 01, 2025 (GLOBE NEWSWIRE) -- The global chromatography membrane filters market is projected to witness a growth rate of 10.0% annually from 2024 to 2030, with an anticipated size of...

- Post-Hoc Analyses Provide Comparative Data on Rescue Criteria and Intervention-Free Rates for Tyrosine Kinase Inhibitors (TKIs) in Wet AMD Development - - Unique Ability to Re-Dose CLS-AX vs Rescue...

Sitryx initiates Phase 1 clinical trial of potential disease-modifying treatment for atopic dermatitis SYX-5219 SYX-5219 is a first-in-class oral PKM2 modulator designed to drive sustained disease...

ニューヨーク州オールバニ発 , March 17, 2025 (GLOBE NEWSWIRE) -- 研究開発・製造業務受託機関のリーダーであるキュリア・グローバル (Curia Global, Inc.)(キュリア) は本日、英国グラスゴー施設の拡張計画を発表し、ニューメキシコ州アルバカーキで進行中の拡張プロジェクトの最新情報を提供した。 ...

ALBANY, N.Y., March 17, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), ein führendes Unternehmen für Auftragsforschungs-, Entwicklungs- und Produktionsunternehmen, gab heute Expansionspläne...

纽约州奥尔巴尼, March 17, 2025 (GLOBE NEWSWIRE) -- 全球领先的合同研究、开发和制造企业 Curia Global, Inc. (Curia) 今日宣布英国格拉斯哥 (Glasgow) 工厂扩建计划，并通报了新墨西哥州阿尔伯克基 (Albuquerque) 工厂持续扩建项目的最新进展。 ...